Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription Articles published in Am J Dermatopathol Retrieve available abstracts of 96 articles: HTML format

Single Articles

July 2026
1. GUNGOR SAHIN G, Eroglu E, Buyukbabani N, Ozturk Sari S, et al
   Comprehensive Immunohistochemical Analysis of Atypical Fibroxanthoma: Focus on PRAME in Differential Diagnosis.
   Am J Dermatopathol. 2026;48:509-514.
   PubMed     Abstract available
   
   
   June 2026
2. HELM TN, Lam C, Zoshchuk B, Helm MF, et al
   PRAME Expression and Melanoma In Situ Margin Assessment.
   Am J Dermatopathol. 2026 Jun 22. doi: 10.1097/DAD.0000000000003349.
   PubMed     Abstract available
   
   
   
3. STEGURA C, Steevens N, Neimy H, Saravanan S, et al
   Assessing Nuclear and Nucleolar Areas Between Malignant Melanoma and Benign Nevi.
   Am J Dermatopathol. 2026 Jun 18. doi: 10.1097/DAD.0000000000003355.
   PubMed     Abstract available
   
   
   
4. MCFADDEN JR, Htoo A, Chaudhari AS, Stevanovic M, et al
   On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study.
   Am J Dermatopathol. 2026 Jun 16. doi: 10.1097/DAD.0000000000003350.
   PubMed     Abstract available
   
   
   
5. OZDEN F, Coskun IS, Kasapgil I
   Melanoma Colonizing Basal Cell Carcinoma: A Rarely Described Entity.
   Am J Dermatopathol. 2026 Jun 11. doi: 10.1097/DAD.0000000000003348.
   PubMed     Abstract available
   
   
   
6. KAZMI M, Melloy MP, Abukhadra S, Terrell JR, et al
   Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma.
   Am J Dermatopathol. 2026 Jun 10. doi: 10.1097/DAD.0000000000003335.
   PubMed    
   
   
   May 2026
7. TRIYANGKULSRI K, Wittayabusarakam N, Smitthisakda S, Sakpuwadol N, et al
   Diagnostic and Prognostic Values of PRAME Immunohistochemistry in Acral Lentiginous Melanoma.
   Am J Dermatopathol. 2026 May 27. doi: 10.1097/DAD.0000000000003305.
   PubMed     Abstract available
   
   
   April 2026
8. YU Y, Sabljic T, Capo-Chichi JM, Kamil ZS, et al
   A Novel PDZRN3::BRAF Fusion as Potential Driver Mechanism in BAP1-inactivated Melanocytoma.
   Am J Dermatopathol. 2026 Apr 17. doi: 10.1097/DAD.0000000000003303.
   PubMed     Abstract available
   
   
   
9. DARUISH M, Ibrahim H
   Malignant Melanoma With Rhabdomyosarcomatous Differentiation: Report of 2 New Cases.
   Am J Dermatopathol. 2026 Apr 8. doi: 10.1097/DAD.0000000000003292.
   PubMed     Abstract available
   
   
   
10. LEIBING T, Schweinsberg V, Franklin C, Hitchcock MG MBCHB, MBA, et al
    Rare Presentation of an NF2-Mutated Desmoplastic Melanoma With Pure Spindle Cell Morphology in a 69-Year-Old Patient.
    Am J Dermatopathol. 2026 Apr 6. doi: 10.1097/DAD.0000000000003283.
    PubMed    
    
    
    
11. SHORE KT, Mochel MC, Karpinski P, Sepehr A, et al
    Clinicopathologic and Molecular Analyses of 2 Basomelanocytic Tumors and Literature Review.
    Am J Dermatopathol. 2026;48:318-326.
    PubMed     Abstract available
    
    
    March 2026
12. CARBONELL-ZAMORANO J, Santonja-Lopez N, Navarro L, Fernandez A, et al
    Clinicopathological Study of a Series of Melanomas With IDH1 Mutation.
    Am J Dermatopathol. 2026 Mar 27. doi: 10.1097/DAD.0000000000003272.
    PubMed     Abstract available
    
    
    
13. GHALI H, Al-Bzour AN, Boby A, Aflatooni S, et al
    Associations Between Pigmentation and the Clinicopathologic and Immune Landscape of Melanoma.
    Am J Dermatopathol. 2026 Mar 20. doi: 10.1097/DAD.0000000000003223.
    PubMed     Abstract available
    
    
    
14. KISZLUK A, Alhalaseh YN, Asar MC, Chen F, et al
    Verhoeff-van Gieson May Distinguish Desmoplastic Melanoma From Re-Excision Scar.
    Am J Dermatopathol. 2026;48:193-196.
    PubMed     Abstract available
    
    
    February 2026
15. LIU J, Liu L, An X
    Deep Learning for Classification and Prognosis of Melanoma in Whole-Slide Images: A Review.
    Am J Dermatopathol. 2026 Feb 26. doi: 10.1097/DAD.0000000000003239.
    PubMed     Abstract available
    
    
    
16. COLBERT MD, Holder K, Tekin B, Buonaccorsi JN, et al
    A Case of Malignant Melanoma With Numerous Wagner-Meissner-Like Bodies.
    Am J Dermatopathol. 2026 Feb 6. doi: 10.1097/DAD.0000000000003240.
    PubMed     Abstract available
    
    
    
17. RUSSOLILLO JK, Schaedler A, Hsia B, Silberstein PT, et al
    Comprehensive Genomic Profiling of Acral Melanoma: Insights From the AACR Project GENIE Database.
    Am J Dermatopathol. 2026 Feb 6. doi: 10.1097/DAD.0000000000003237.
    PubMed     Abstract available
    
    
    
18. LI Y, Hutchison DM, Linden KG, Lee BA, et al
    Diagnostic Utility of Molecular Profiling in a Giant Cellular Blue Nevus.
    Am J Dermatopathol. 2026;48:94-99.
    PubMed     Abstract available
    
    
    January 2026
19. WRIGHT BB, Walters R, Googe P, Al-Rohil RN, et al
    Melanocytoma With Morphologic Features Reminiscent of BAP-1-Inactivated Melanocytoma but With a Different Molecular Profile.
    Am J Dermatopathol. 2026 Jan 2. doi: 10.1097/DAD.0000000000003209.
    PubMed     Abstract available
    
    
    
20. MURPHY K, Helm MF, Pameijer C, Miller J, et al
    Pruritic Papular Eruption in a Male Receiving TVEC for Metastatic Melanoma.
    Am J Dermatopathol. 2026;48:e5-e6.
    PubMed    
    
    
    
21. MURPHY K, Helm MF, Pameijer C, Miller J, et al
    Pruritic Papular Eruption in a Male Receiving TVEC for Metastatic Melanoma: Answer.
    Am J Dermatopathol. 2026;48:72.
    PubMed    
    
    
    December 2025
22. IZOL H, Kolak Gozukucuk G, Bagbudar S, Caskan P, et al
    Evaluation of Preferentially Expressed Antigen in Melanoma Expression and Epidemiologic Features in Dysplastic Nevi: A Comparative Analysis of Low- and High-Grade Lesions.
    Am J Dermatopathol. 2025 Dec 26. doi: 10.1097/DAD.0000000000003203.
    PubMed     Abstract available
    
    
    
23. TAUZIEDE-ESPARIAT A, Poilane C, Gleize D, Bouvier B, et al
    BRAFV600E and NRASQ61R Antibodies Are Sensitive and Specific Diagnostic Biomarkers for BRAF and NRAS Mutations in Conjunctival Melanomas.
    Am J Dermatopathol. 2025 Dec 8. doi: 10.1097/DAD.0000000000003183.
    PubMed    
    
    
    
24. MAAROUF S, Alomari AK
    A Challenging Diagnosis of Primary Cutaneous Melanoma With Rhabdomyosarcomatous Differentiation: A Case Study and Review of the Literature.
    Am J Dermatopathol. 2025 Dec 4. doi: 10.1097/DAD.0000000000003181.
    PubMed     Abstract available
    
    
    
25. MAXWELL A, Sanchez C, Axcell K, Helm TN, et al
    Rapidly Developing Pigmented Lesions in a Patient With Melanoma: Challenge.
    Am J Dermatopathol. 2025;47:e139-e141.
    PubMed    
    
    
    
26. MAXWELL A, Sanchez C, Axcell K, Helm TN, et al
    Rapidly Developing Pigmented Lesions in a Patient With Melanoma: Answer.
    Am J Dermatopathol. 2025;47:981-982.
    PubMed    
    
    
    November 2025
27. BENINI A, Ortiz DC, Sola S, Chiodi S, et al
    Undifferentiated Melanoma Mimicking Pleomorphic Dermal Sarcoma: Two Additional Cases With Follow-Up Data and Short Literature Review.
    Am J Dermatopathol. 2025 Nov 17. doi: 10.1097/DAD.0000000000003137.
    PubMed     Abstract available
    
    
    
28. WOOD BA, Shepard S, James C, Harvey NT, et al
    BAP1-Inactivated Melanocytic Tumors With Distinctive p16-Negative Clonal Growth and Liver Metastases.
    Am J Dermatopathol. 2025 Nov 14. doi: 10.1097/DAD.0000000000003151.
    PubMed     Abstract available
    
    
    
29. FORTAREZZA F, Ciolfi C, Scolaro F, Poputchikova A, et al
    Superficial Spreading Melanoma Combined With WNT-Activated Deep Penetrating/Plexiform Melanocytoma: Report of an Inedited Association.
    Am J Dermatopathol. 2025;47:871-873.
    PubMed    
    
    
    October 2025
30. DO J, Yang RK, Curry JL, Cho WC, et al
    Fatal Melanoma With MAP4::RAF1 Fusion: Expanding the Clinicopathologic and Prognostic Spectrum of RAF1-Fused Melanomas.
    Am J Dermatopathol. 2025 Oct 31. doi: 10.1097/DAD.0000000000003162.
    PubMed     Abstract available
    
    
    
31. MAHURIN H, Flanagan K, Wang Y, Ruhoy SM, et al
    Atypical Deep Penetrating Melanocytic Tumors and Melanomas With Beta Catenin Mutations. A Case Series.
    Am J Dermatopathol. 2025 Oct 17. doi: 10.1097/DAD.0000000000003131.
    PubMed     Abstract available
    
    
    September 2025
32. HE LJ, Hornick JL, Russell-Goldman E
    Methylthioadenosine Phosphorylase (MTAP) and p16 Expression in Melanocytic Nevi and Melanoma with Molecular Correlation.
    Am J Dermatopathol. 2025 Sep 26. doi: 10.1097/DAD.0000000000003139.
    PubMed     Abstract available
    
    
    August 2025
33. REGMI A, Parra O, Ma W, LeBlanc RE, et al
    Evaluating the Diagnostic Concordance of MyPath Melanoma Assay and PRAME Immunohistochemistry in Challenging Melanocytic Lesions.
    Am J Dermatopathol. 2025 Aug 28. doi: 10.1097/DAD.0000000000003018.
    PubMed     Abstract available
    
    
    
34. HIRAI I, Walker JL, Rubin AI, Chu EY, et al
    CRTC1::TRIM11 Cutaneous Tumor Mimicking Primary Dermal Melanoma: Case Report With Literature Review.
    Am J Dermatopathol. 2025 Aug 26. doi: 10.1097/DAD.0000000000003108.
    PubMed     Abstract available
    
    
    
35. ZOU Y, Li L, Xia R, Wang F, et al
    Accuracy of Confocal Microscopy for the Diagnosis of Acral Lentiginous Melanoma and Acral Melanocytic Nevi.
    Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003099.
    PubMed     Abstract available
    
    
    
36. ADDO AK, Beydoun HM, Jeyakumar JE, Olivares S, et al
    The Morphologic Spectrum of NF Mutated Desmoplastic Melanocytic Neoplasms.
    Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003056.
    PubMed     Abstract available
    
    
    July 2025
37. HARRIS MS, Castaneda C, Wieland A, Bennett DD, et al
    Malignant Melanoma With Transdifferentiation Into a Ganglioneuroblastic Phenotype After Anti-PD-1 Therapy.
    Am J Dermatopathol. 2025 Jul 28. doi: 10.1097/DAD.0000000000003080.
    PubMed     Abstract available
    
    
    
38. DELLA MURA M, Sorino J, Colagrande A, Ingravallo G, et al
    Atypical Spitz Tumor/Spitz Melanocytoma Revealing a VIM::NTRK3 Gene Fusion: Clinicopathological Correlation of a Unique Molecular Finding.
    Am J Dermatopathol. 2025 Jul 1. doi: 10.1097/DAD.0000000000003051.
    PubMed     Abstract available
    
    
    June 2025
39. CHO WC, Yang RK, Lenskaya V, Prieto VG, et al
    SBF1::BRAF-Fused Melanoma With Prominent Rhabdoid Morphology and Reed-Sternberg-Like Cells: Potential Morphologic Clues to BRAF-Fused Melanomas of Non-Spitz Lineage?
    Am J Dermatopathol. 2025 Jun 26. doi: 10.1097/DAD.0000000000003048.
    PubMed    
    
    
    
40. URSO C
    Primary Cutaneous Melanoma With Sebocyte-like Melanocytes: Case Report and Review of the Literature.
    Am J Dermatopathol. 2025 Jun 26. doi: 10.1097/DAD.0000000000003007.
    PubMed     Abstract available
    
    
    
41. MUJEB A, Paez-Garcia MS, Musolff N, Tchack M, et al
    Significance of Sectioning (Breadloafing) the Entire Skin Tissue When Pathology Does Not Match Clinical Appearance.
    Am J Dermatopathol. 2025 Jun 26. doi: 10.1097/DAD.0000000000003046.
    PubMed     Abstract available
    
    
    
42. MEIJS-HERMANNS PR, Spitzer-Naaijkens JMJ, Kester LA, Jansen AML, et al
    A Stranger in the Slide: A Rare Collision of a Spitz Melanocytoma With a Novel MYH9::LTK Fusion and a Common BRAF Mutated Nevus Mimicking a Melanoma With a Preexistent Nevus.
    Am J Dermatopathol. 2025 Jun 25. doi: 10.1097/DAD.0000000000003039.
    PubMed     Abstract available
    
    
    
43. SCHIRWANI S, Theaker J, Side L, Moutasim K, et al
    Atypical Spitz Tumor (Spitz Melanocytoma) With Lymph Node Metastasis and Long-Term Clinical Follow-Up.
    Am J Dermatopathol. 2025 Jun 23. doi: 10.1097/DAD.0000000000002982.
    PubMed     Abstract available
    
    
    
44. KUNZLER E, Enos C, Bohannon M, Walker A, et al
    The University of Florida Dermatopathology Experience With the Pigmented Lesion Assay.
    Am J Dermatopathol. 2025;47:468-471.
    PubMed     Abstract available
    
    
    April 2025
45. VAVRUKH P, LeBlanc RE, Yan S
    Diagnostic Utility of Preferentially Expressed Antigen in Melanoma (PRAME) and p16 Immunohistochemistry in Distinguishing Genital Melanomas From Benign Melanocytic Proliferations.
    Am J Dermatopathol. 2025 Apr 22. doi: 10.1097/DAD.0000000000002977.
    PubMed     Abstract available
    
    
    March 2025
46. SHAKER N, Niu S, Blankenship H, Shaker N, et al
    Artificial Intelligence and Convolutional Neural Networks-Driven Detection of Micro and Macro Metastasis of Cutaneous Melanoma to the Lymph Nodes.
    Am J Dermatopathol. 2025 Mar 19. doi: 10.1097/DAD.0000000000002954.
    PubMed     Abstract available
    
    
    February 2025
47. GAO Y, Yang RK, Curry JL, Torres-Cabala CA, et al
    Melanoma With RNF11::BRAF Fusion: A Novel Fusion Previously Undescribed in Melanoma.
    Am J Dermatopathol. 2025 Feb 25. doi: 10.1097/DAD.0000000000002936.
    PubMed     Abstract available
    
    
    
48. KOGA S, Karakousis GC, Yang G, Elder DE, et al
    Late Recurrent Spitz Melanoma With a TMEM106B::BRAF Fusion.
    Am J Dermatopathol. 2025 Feb 19. doi: 10.1097/DAD.0000000000002946.
    PubMed     Abstract available
    
    
    
49. SHAKER N, Phelps R, Niedt G, Sangueza O, et al
    BRCA1-Associated Protein-1 Inactivated Melanoma Arising in a Pre-existing Nevus With ALK Fusion and Low Tumor Mutational Burden.
    Am J Dermatopathol. 2025 Feb 6. doi: 10.1097/DAD.0000000000002925.
    PubMed     Abstract available
    
    
    
50. KNITTEL RJ, Harvey NT, Ardakani NM, O'Brien B, et al
    Clinicopathologic Features of PRAME-Positive Common Melanocytic Nevi: A Case-Control Study.
    Am J Dermatopathol. 2025 Feb 6. doi: 10.1097/DAD.0000000000002932.
    PubMed     Abstract available
    
    
    December 2024
51. TIRUMALAE R, Correa M, Manjunath S
    Intramuscular Cellular Nodules in a Congenital Large Plaque-Like Blue Nevus: Melanoma or Not?
    Am J Dermatopathol. 2024 Dec 31. doi: 10.1097/DAD.0000000000002906.
    PubMed     Abstract available
    
    
    
52. FERNANDEZ-FLORES A
    "Pathway Leap": A New Molecular Phenomenon to Consider in the Pathogenesis of Melanocytic Tumors.
    Am J Dermatopathol. 2024 Dec 31. doi: 10.1097/DAD.0000000000002916.
    PubMed     Abstract available
    
    
    
53. YAVUZ A, Simsek K, Bassorgun CI, Elpek GO, et al
    The Prognostic Significance of Tumor Budding and Tumor-Infiltrating Lymphocytes in Patients Diagnosed With Malignant Melanoma.
    Am J Dermatopathol. 2024 Dec 10. doi: 10.1097/DAD.0000000000002902.
    PubMed     Abstract available
    
    
    November 2024
54. MACHUCA-AGUADO J, Lopez-Prieto A, Mora-Diaz R, Gutierrez-Domingo A, et al
    PRAME Immunostaining in BAP-1-Inactivated Melanocytic Tumors: Unraveling Diagnostic Complexity and Exploring Germline Mutation Associations.
    Am J Dermatopathol. 2024 Nov 7. doi: 10.1097/DAD.0000000000002717.
    PubMed     Abstract available
    
    
    October 2024
55. FERNANDEZ-FLORES A
    Selective Clonal Regression After Interferon Therapy in Metastatic Melanoma.
    Am J Dermatopathol. 2024 Oct 31. doi: 10.1097/DAD.0000000000002873.
    PubMed     Abstract available
    
    
    
56. KOSSARD S, Sharifi S, Calvey L
    Utilizing PRAME Expression and a Meta-Analytic Framework for iSALT to Explore Atypical Late-Onset Nevi of the Elderly and Their Relationship With Lentiginous and Nested Nevoid Melanomas.
    Am J Dermatopathol. 2024 Oct 15. doi: 10.1097/DAD.0000000000002847.
    PubMed     Abstract available
    
    
    
57. ASATO MA, Moraes Neto FA, Moraes MPT, Ocanha-Xavier JP, et al
    The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma.
    Am J Dermatopathol. 2024 Oct 15. doi: 10.1097/DAD.0000000000002863.
    PubMed     Abstract available
    
    
    September 2024
58. DARUISH M, Kerr G, Taibjee S
    A Combined Spindle Cell Melanoma and Sarcomatoid Squamous Cell Carcinoma: A Rather Unique Squamomelanocytic Tumor.
    Am J Dermatopathol. 2024 Sep 17. doi: 10.1097/DAD.0000000000002838.
    PubMed     Abstract available
    
    
    
59. SINGH P, Wu D, Karunamurthy A, Seynnaeve BKN, et al
    Pediatric Melanoma With a Rare BRAF V600K Mutation.
    Am J Dermatopathol. 2024 Sep 17. doi: 10.1097/DAD.0000000000002835.
    PubMed    
    
    
    
60. RUZ PORTERO B, Garcia de Sola Llamas C, Perez Perez M, Sanchez Bernal ML, et al
    Cellular Schwannoma Mimicking a Nodular Melanoma on the Sole of the Foot, an Avoidable Diagnostic Pitfall.
    Am J Dermatopathol. 2024;46:e79-e83.
    PubMed     Abstract available
    
    
    August 2024
61. VAN SAMBEEK S, Friedlander E, Patino WD
    A Retrospective Review: Our Experience With an Adhesive-Based Pigmented Lesion Assay Used to Evaluate Cutaneous Lesions Suspicious for Melanoma.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002759.
    PubMed     Abstract available
    
    
    
62. DARUISH M, Karunaratne S, Duffy-Gadd P, Hansford S, et al
    Utility of PRAME Immunohistochemistry in the Detection of Subtle Melanoma Microsatellites.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002817.
    PubMed     Abstract available
    
    
    
63. NG S, Hall KC, Busam KJ, Lezcano C, et al
    Superficial Wnt-Activated Melanocytic Nevi/Melanocytomas With a Junctional Component: A Case Series.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002804.
    PubMed     Abstract available
    
    
    
64. GOLDBERG MS, Cockerell CJ, Rogers JH, Siegel JJ, et al
    Appropriate Statistical Methods to Assess Cross-study Diagnostic 23-Gene Expression Profile Test Performance for Cutaneous Melanocytic Neoplasms.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002808.
    PubMed     Abstract available
    
    
    July 2024
65. FIELDS BC, Jain AJ, Prieto VG, Frink SJ, et al
    Pigmented Villonodular Synovitis: A Metastatic Melanoma Imitator.
    Am J Dermatopathol. 2024 Jul 12. doi: 10.1097/DAD.0000000000002771.
    PubMed     Abstract available
    
    
    
66. IBRAHIM E, Yang RK, Curry JL, Cho WC, et al
    BCR::ZNF711 and BCR::CYLC2 Fusions: Novel BCR Fusions Expanding the Molecular Spectrum of Gene Fusions in Melanoma.
    Am J Dermatopathol. 2024 Jul 12. doi: 10.1097/DAD.0000000000002796.
    PubMed    
    
    
    June 2024
67. CHO WC, Prieto VG, Yang RK
    Spitz Melanoma With SLC20A1::ALK Fusion: A Novel Fusion Previously Undescribed in Spitz Melanocytic Neoplasm.
    Am J Dermatopathol. 2024 Jun 28. doi: 10.1097/DAD.0000000000002778.
    PubMed     Abstract available
    
    
    
68. CHEN JM, Hernandez E, Frosina D, Ruh PA, et al
    In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1).
    Am J Dermatopathol. 2024 Jun 28. doi: 10.1097/DAD.0000000000002772.
    PubMed     Abstract available
    
    
    
69. MERT M, Bozdogan O, Bozdogan N, Gamsizkan M, et al
    PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors.
    Am J Dermatopathol. 2024 Jun 20. doi: 10.1097/DAD.0000000000002768.
    PubMed     Abstract available
    
    
    
70. KNITTEL R, Rogers S, Wood BA
    Cutaneous Seeding of Glioblastoma: A Case Report and Literature Review.
    Am J Dermatopathol. 2024 Jun 6. doi: 10.1097/DAD.0000000000002748.
    PubMed     Abstract available
    
    
    May 2024
71. LEDESMA DA, Marques-Piubelli ML, Li-Ning-Tapia E, Hudgens C, et al
    Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma.
    Am J Dermatopathol. 2024 May 7. doi: 10.1097/DAD.0000000000002635.
    PubMed     Abstract available
    
    
    
72. SU S, Liu J, Jiang Y
    Rare Presentation of Melanoma Recurrences With Diffuse Subcutaneous Intravascular Lesions: A Novel In-Transit Metastases Pattern.
    Am J Dermatopathol. 2024 May 7. doi: 10.1097/DAD.0000000000002735.
    PubMed     Abstract available
    
    
    April 2024
73. SRIVATSA S, Smith CJ, Sangueza OP, Miedema J, et al
    Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old Man.
    Am J Dermatopathol. 2024 Apr 4. doi: 10.1097/DAD.0000000000002696.
    PubMed     Abstract available
    
    
    March 2024
74. LOPER R, Schon MP, Mitteldorf C
    Melanocyte Density in the Diagnosis of Melanoma In Situ in Sun-Damaged Skin.
    Am J Dermatopathol. 2024 Mar 19. doi: 10.1097/DAD.0000000000002680.
    PubMed     Abstract available
    
    
    
75. CASILLAS AC, Muhlbauer A, Barragan VA, Jefferson I, et al
    A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
    Am J Dermatopathol. 2024;46:137-146.
    PubMed     Abstract available
    
    
    
76. LOHMAN ME, Kim YH, Steen AJ, Demer AM, et al
    The Promise and Pitfalls of PRAME Immunohistochemistry During Mohs Surgery: Early Findings.
    Am J Dermatopathol. 2024;46:191-192.
    PubMed    
    
    
    February 2024
77. MACHUCA-AGUADO J, Garcia-Trevijano CI, Orrego-Pereira C, Montana-Ramirez AM, et al
    Unraveling PRAME Expression in Desmoplastic Melanocytic Neoplasms: Illuminating its Diagnostic Significance in Distinguishing Desmoplastic Spitz Nevi.
    Am J Dermatopathol. 2024 Feb 7. doi: 10.1097/DAD.0000000000002638.
    PubMed    
    
    
    January 2024
78. WILLS A, Dibbern M, Frierson HF, Raghavan SS, et al
    Metastatic Undifferentiated Melanoma Mimicking a Primary Bone Tumor: A Potential Diagnostic Pitfall.
    Am J Dermatopathol. 2024 Jan 3. doi: 10.1097/DAD.0000000000002622.
    PubMed     Abstract available
    
    
    December 2023
79. MCTIGHE SP, Taylor EA, Allbritton J, Lewin-Smith MR, et al
    Localized Cutaneous Argyria at the Site of a Prior Melanoma Excision Confirmed by Scanning Electron Microscopy With Energy Dispersive X-ray Analysis.
    Am J Dermatopathol. 2023 Dec 26. doi: 10.1097/DAD.0000000000002610.
    PubMed     Abstract available
    
    
    November 2023
80. NEIMY H, Helmy JE, Snyder A, Valdebran M, et al
    Artificial Intelligence in Melanoma Dermatopathology: A Review of Literature.
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002593.
    PubMed     Abstract available
    
    
    
81. KENNY MG, Nguyen M, Modi M, Eilers D, et al
    Melanoma Mimicker: Pigmented Mammary Paget Disease in a Man.
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002588.
    PubMed     Abstract available
    
    
    
82. TURNER N, Ko CJ, McNiff JM, Galan A, et al
    Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review.
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002584.
    PubMed     Abstract available
    
    
    
83. DONATI M, Grossmann P, Mansour B, Kazakov DV, et al
    Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002556.
    PubMed     Abstract available
    
    
    
84. KIM JC, Choi JW, Kim YC
    Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi.
    Am J Dermatopathol. 2023;45:748-752.
    PubMed     Abstract available
    
    
    
85. LEZCANO C, Jungbluth AA, Busam KJ
    Immunohistochemistry for PRAME in Dermatopathology.
    Am J Dermatopathol. 2023;45:733-747.
    PubMed     Abstract available
    
    
    August 2023
86. VANDERBECK K, Rothrock AT, Cho WC, Nagarajan P, et al
    PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls.
    Am J Dermatopathol. 2023;45:549-556.
    PubMed     Abstract available
    
    
    
87. WEN D, Chen T, Martin RCW
    A Rare Case of a Basomelanocytic Tumor.
    Am J Dermatopathol. 2023;45:e64-e67.
    PubMed     Abstract available
    
    
    July 2023
88. OCANHA XAVIER JP, Xavier JCC Jr, da Silva MG, Marques MEA, et al
    Vitamin D Receptor and Retinoid X Receptor Alpha in Melanocytic Benign Lesions and Melanoma.
    Am J Dermatopathol. 2023 Jul 28. doi: 10.1097/DAD.0000000000002507.
    PubMed     Abstract available
    
    
    
89. SHERIDAN C, O'Connor MC, Sitton B, Bass J, et al
    Nevus Spilus With Dermatoheliosis: A Histologic Mimicker of Melanoma in Situ at Melanoma Excision Margins.
    Am J Dermatopathol. 2023 Jul 11. doi: 10.1097/DAD.0000000000002493.
    PubMed     Abstract available
    
    
    
90. BOUTKO A, Hagstrom M, Lampley N, Roth A, et al
    PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Am J Dermatopathol. 2023;45:437-447.
    PubMed     Abstract available
    
    
    May 2023
91. O'NEILL P, Amanuel B, Mesbah Ardakani N
    Cutaneous Malignant Melanoma With Rhabdomyosarcomatous Dedifferentiation: an Immunohistological and Molecular Case Study With Literature Review.
    Am J Dermatopathol. 2023 May 2. doi: 10.1097/DAD.0000000000002451.
    PubMed     Abstract available
    
    
    
92. MCFADDEN JR, Syku M, Barney RE, Stevanovic M, et al
    A Novel Method to Detect Copy Number Variation in Melanoma: Droplet Digital PCR for Quantitation of the CDKN2A Gene, a Proof-of-Concept Study.
    Am J Dermatopathol. 2023 May 2. doi: 10.1097/DAD.0000000000002436.
    PubMed     Abstract available
    
    
    April 2023
93. PISANI D, Micallef D, Scerri J, Betts A, et al
    Neuroendocrine Transdifferentiation in Cutaneous Melanoma: A Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:264-268.
    PubMed     Abstract available
    
    
    
94. CORTEZ DE ALMEIDA RF, Sponchiado Assoni A, Cabrera Pereira JP, Erthal de Britto Pereira Kassuga Roisman L, et al
    Pigmented Bowen Disease in the Acral Region: A Diagnostic Challenge.
    Am J Dermatopathol. 2023;45:235-236.
    PubMed    
    
    
    March 2023
95. MCFADDEN JR, Chaudhari AS, Stevanovic M, Tsongalis GJ, et al
    Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
    Am J Dermatopathol. 2023 Mar 20. doi: 10.1097/DAD.0000000000002420.
    PubMed     Abstract available
    
    
    February 2023
96. BOUTKO A, Asadbeigi S, Roth A, Lampley N, et al
    TERT Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms.
    Am J Dermatopathol. 2023 Feb 17. doi: 10.1097/DAD.0000000000002366.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum